Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lysergic acid diethylamide by Mind Medicine MindMed for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Generalized Anxiety Disorder...
Lysergic acid diethylamide by Mind Medicine MindMed for Major Depressive Disorder: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder....
Mescaline by Mind Medicine MindMed for Unspecified Psychiatric Disorders: Likelihood of Approval
Mescaline is under clinical development by Mind Medicine MindMed and currently in Phase I for Unspecified Psychiatric Disorders. According to...
Lysergic acid diethylamide by Mind Medicine MindMed for Pain: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase I for Pain. According to...
Lysergic acid diethylamide by Mind Medicine MindMed for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Generalized Anxiety Disorder...
Lysergic acid diethylamide by Mind Medicine MindMed for Major Depressive Disorder: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder....
MM-402 by Mind Medicine MindMed for Autism Spectrum Disorder (ASD): Likelihood of Approval
MM-402 is under clinical development by Mind Medicine MindMed and currently in Phase I for Autism Spectrum Disorder (ASD). According...
Risk adjusted net present value: What is the current valuation of Mind Medicine MindMed's Lysergic Acid Diethylamide?
Lysergic Acid Diethylamide is a small molecule commercialized by Mind Medicine MindMed, with a leading Phase II program in Major...